For Patients & Families > Clinical Research

Clinical Research at Farber

The Farber Institute's overall mission is to translate new understandings in basic neuroscience into therapies for CNS disorders. Farber's growing clinical research program serve as a critical extension to the Institute's extensive "disease-driven" basic and preclinical research

Please select from the list below for more information on research programs:

• Farber Institute Launches Anti-Amyloid Clinical Trials
  • Phase 3 Study of Alzhemed for Mild to Moderate Alzheimer's
  • Phase 2 Study of Lecozotan for Mild to Moderate Alzheimer's (Ongoing; No New Enrollment)
  • Phase 3 Study of Flurizan for Mild to Moderate Alzheimer's
• Help for Drug-Dependent Newborns

Researchers' Bio Pages

• Barry Rovner, M.D.